Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.

Rowland, R; Pathan, AA; Satti, I; Poulton, ID; Matsumiya, MM; Whittaker, M; Minassian, AM; O'Hara, GA; Hamill, M; Scott, JT; +9 more... Harris, SA; Poyntz, HC; Bateman, C; Meyer, J; Williams, N; Gilbert, SC; Lawrie, AM; Hill, AV; McShane, H; (2013) Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial. Human vaccines & immunotherapeutics, 9 (1). pp. 50-62. ISSN 2164-5515 DOI: https://doi.org/10.4161/hv.22464

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.4161/hv.22464

Abstract

Share

Download

Filename: hvi-9-50.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar